Antón M D, Serra M A, Del Olmo J, Rodrigo J M
Service of Hepatology, Universitary Clinic Hospital, Valencia, Spain.
Rev Esp Enferm Dig. 1997 Aug;89(8):599-610.
We studied 104 patients diagnosed with hepatocellular carcinoma on the basis of pathological findings, in order to establish differences between patients with and without liver cirrhosis in addition to carcinoma. Among the former we also tried to identify differences between patients with previously diagnosed cirrhosis and those in whom cirrhosis was diagnosed at the same time as carcinoma. No significant differences were observed between patients in whom cirrhosis was diagnosed before or at the same time as carcinoma in relation to age, sex, etiologic factors or Child-Pugh grade. Differences were found with regard to motives for suspecting a tumor, frequency of splenomegaly, and platelet and leukocyte counts. No significant differences were found between patients with and without cirrhosis except in some laboratory findings (leukocytes, platelets, erythrocyte sedimentation rate and gammaglutamyl transpeptidase higher in the latter group, and alpha-fetoprotein higher in the former). There were no significant differences between cases of hepatocellular carcinoma that appeared as the first manifestation of liver cirrhosis and those that were diagnosed in patients with known cirrhosis. The clinical and biological differences between patients with and without cirrhosis can be explained by the associated chronic hepatic disease.
我们对104例经病理检查确诊为肝细胞癌的患者进行了研究,目的是明确除癌症外,伴有和不伴有肝硬化的患者之间的差异。在前者中,我们还试图找出先前已诊断出肝硬化的患者与在诊断癌症的同时被诊断出肝硬化的患者之间的差异。在癌症之前或同时被诊断出肝硬化的患者,在年龄、性别、病因或Child-Pugh分级方面未观察到显著差异。在怀疑肿瘤的动机、脾肿大的频率以及血小板和白细胞计数方面发现了差异。除了一些实验室检查结果外(后者组白细胞、血小板、红细胞沉降率和γ-谷氨酰转肽酶较高,而前者组甲胎蛋白较高),伴有和不伴有肝硬化的患者之间未发现显著差异。作为肝硬化首发表现出现的肝细胞癌病例与在已知肝硬化患者中诊断出的病例之间没有显著差异。伴有和不伴有肝硬化的患者之间的临床和生物学差异可以用相关的慢性肝病来解释。